Skip to main content

How I Read Cancer Imaging Studies: The Master Class Series

Surprisingly, in contrast to the literature regarding the outcomes of imaging, the methods that underpin the generation of a report and how to communicate the findings cogently to referring clinicians remains something of a “black box”.

This series of articles appearing in Cancer Imaging showcases experts in various modalities detailing their approach to reporting scans in particular disease settings. We hope that you will be excited to discover this data, which has traditionally been locked into the brains of experts and only intermittently shared with their own direct trainees or alternatively, at often expensive masterclass presentations.

Read the introductory Editorial for ‘How I read cancer imaging studies: the master class series’ written by Prof Rodney Hicks, Editor-in-Chief of Cancer Imaging.

-------------------------------------------------------------------------------------------------------

  1. Positron Emission Tomography with Computed Tomography (PET/CT) is widely used in the assessment of many diseases, particularly including cancer. However, many factors can affect image quality and diagnostic pe...

    Authors: David Dudoignon, David A. Pattison, Damien Legallois, Rodney J. Hicks and Nicolas Aide

    Citation: Cancer Imaging 2020 20:68

    Content type: Review

    Published on:

  2. Evaluate the feasibility of fluorine-18 (18F) fluorodeoxyglucose (FDG) positron emission tomography (PET) and magnetic resonance (MR) imaging in patients with gastric cancer by optimizing the scan protocol and to...

    Authors: Dong Zheng, Yi Liu, Jiajin Liu, Ke Li, Mu Lin, Holger Schmidt, Baixuan Xu and Jiahe Tian

    Citation: Cancer Imaging 2020 20:39

    Content type: Research article

    Published on:

  3. Oncological diseases account for a significant portion of the burden on public healthcare systems with associated costs driven primarily by complex and long-lasting therapies. Through the visualization of pati...

    Authors: Thomas Beyer, Luc Bidaut, John Dickson, Marc Kachelriess, Fabian Kiessling, Rainer Leitgeb, Jingfei Ma, Lalith Kumar Shiyam Sundar, Benjamin Theek and Osama Mawlawi

    Citation: Cancer Imaging 2020 20:38

    Content type: Review

    Published on:

  4. The Vesical Imaging-Reporting and Data System (VI-RADS) was created in 2018, and a 5-point VI-RADS scoring system was proposed to determine whether the muscularis of the bladder has been infiltrated by tumor t...

    Authors: Ziyong Wang, Yunyun Shang, Ting Luan, Yi Duan, Jiansong Wang, Haifeng Wang and Jingang Hao

    Citation: Cancer Imaging 2020 20:26

    Content type: Research article

    Published on:

  5. iRECIST for the objective monitoring of immunotherapies was published by the official RECIST working group in 2017.

    Authors: Thorsten Persigehl, Simon Lennartz and Lawrence H. Schwartz

    Citation: Cancer Imaging 2020 20:2

    Content type: Review

    Published on:

  6. Technical advances in imaging are well demonstrated by MRI (Magnetic Resonance Imaging) and PET (Positron Emission Tomography). Excellent anatomical detail and a lack of ionising radiation make MRI the standar...

    Authors: Arian Lasocki and Rodney J. Hicks

    Citation: Cancer Imaging 2019 19:57

    Content type: Review

    Published on:

  7. The Liver Imaging Reporting and Data System (LI-RADS) standardizes the interpretation and reporting of imaging examinations in patients at risk for hepatocellular carcinoma (HCC). For focal liver observations ...

    Authors: Wolfgang Schima and Jay Heiken

    Citation: Cancer Imaging 2018 18:14

    Content type: Review

    Published on:

  8. PET/CT plays an important role in the diagnosis, staging and management of many pediatric malignancies. The techniques for performing PET/CT examinations in children have evolved, with increasing attention foc...

    Authors: Gabrielle C. Colleran, Neha Kwatra, Leah Oberg, Frederick D. Grant, Laura Drubach, Michael J. Callahan, Robert D. MacDougall, Frederic H. Fahey and Stephan D. Voss

    Citation: Cancer Imaging 2017 17:28

    Content type: Review

    Published on:

  9. Over the last decade, 18F-fluorocholine positron emission tomography/computed tomography (FCH-PET/CT) has gained in popularity for the staging and restaging of patients with prostate cancer (PCa). However, despit...

    Authors: Jean-Mathieu Beauregard and Alexis Beaulieu

    Citation: Cancer Imaging 2016 16:41

    Content type: Review

    Published on:

  10. 18F-fluorodeoxyglucose (FDG) PET/CT is a pivotal imaging modality for cancer imaging, assisting diagnosis, staging of patients with newly diagnosed malignancy, restaging following therapy...

    Authors: Michael S. Hofman and Rodney J. Hicks

    Citation: Cancer Imaging 2016 16:35

    Content type: Review

    Published on:

  11. Liver tumours are fortunately rare in children. Benign tumours such as haemangiomas and cystic mesenchymal hamartomas are typically seen in infancy, often before 6 months of age. After that age, malignant hepa...

    Authors: Susan C. Shelmerdine, Derek J. Roebuck, Alexander J. Towbin and Kieran McHugh

    Citation: Cancer Imaging 2016 16:21

    Content type: Review

    Published on:

  12. Recently, positron emission tomography (PET) imaging using PSMA-ligands has gained high attention as a promising new radiotracer in patients with prostate cancer (PC). Several studies promise accurate staging ...

    Authors: Isabel Rauscher, Tobias Maurer, Wolfgang P. Fendler, Wieland H. Sommer, Markus Schwaiger and Matthias Eiber

    Citation: Cancer Imaging 2016 16:14

    Content type: Review

    Published on:

  13. Endometrial cancer is the most common malignancy of the female pelvis. New concepts in endometrial cancer treatment emphasize the value of MRI as a major predictor of lymph node metastasis and tumour recurrenc...

    Authors: Matthias Meissnitzer and Rosemarie Forstner

    Citation: Cancer Imaging 2016 16:11

    Content type: Review

    Published on: